New AIDS treatments reported at annual retroviral conference

Researchers involved in developing new treatments for the virus reported varying successes with their research at the annual retrovirus conference, including one involving a drug taken for 24 weeks at a rate of two doses a day to reduce levels of the virus in the blood by 97%. Researchers also unveiled a new class of antivirals called "maturation inhibitors," which stop mature virus particles from releasing into the blood.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL